Robinson James A. Jr.insider trades

In SEC Form 4 filings, Robinson James A. Jr. is listed as Director of UroGen Pharma Ltd. (URGN). Robinson James A. Jr. reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Aug 28.

Companies and roles

Company	Role	Transactions	Last filed
URGNUroGen Pharma Ltd.	Director	2	Aug 28

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-08-28

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
URGNUroGen Pharma Ltd.	Aug 26	Aug 28	M	2,000	not reported	not reported	8,000	No	Form 4
URGNUroGen Pharma Ltd.	Aug 26	Aug 28	M · derivative	2,000	$0.00	$0	not reported	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.